Chan Kwon Park

Chan Kwon Park

Auto-generated profile, based on publicly available information

Chan Kwon Park

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
TATai Joon An
Tai Joon An
YYYeun Jie Yoo
Yeun Jie Yoo
JLJeong Uk Lim
Jeong Uk Lim
WSWan Seo
Wan Seo
CPChan Kwon Park
Chan Kwon Park
HYHyoung Kyu Yoon
Hyoung Kyu Yoon
Background: Evaluating the diaphragm muscle in chronic obstructive pulmonary disease (COPD) is important. However, the role of diaphragm ultrasound (DUS) in distinguishing the exacerbation status of COPD (AECOPD) is not fully understood. We set this study to evaluate the role of DUS as a biomarker for distinguishing the AECOPD. Methods: COPD patients who underwent DUS were enrolled between March 2020 and November 2020. The diaphragm thickening fraction (TFmax) and diaphragm excursion (DEmax) during maximal deep breathing were measured. Patients were divided into exacerbation and stable groups. Demographics, lung function, and DUS findings were compared between the two groups. Receiver operating characteristic curve and univariate/multivariate logistic regression analyses were performed. Results: Fifty-five patients were enrolled. The exacerbation group had a lower body mass index (BMI) (20.9 vs 24.2, p = 0.003), lower TFmax (94.8 ± 8.2% vs 158.4 ± 83.5%, p = 0.010), and lower DEmax (30.8 ± 11.1 mm vs 40.5 ± 12.5 mm, p = 0.007) compared to stable group. The areas under the TFmax (0.745) and DEmax (0.721) curves indicated fair results for distinguishing AECOPD. The patients were divided into low and high TFmax and DEmax groups based on calculated cut-off values. Low TFmax (odds ratio [OR] 8.40; 95% confidence interval [CI] 1.55– 45.56) and low DEmax (OR 11.51; 95% CI 1.15– 115.56) were associated with AECOPD after adjusting for age, sex, BMI, and lung functions. Conclusion: DUS showed the possibility of an imaging biomarker distinguishing AECOPD from stable status.

1 April 2019 in Tuberculosis and Respiratory Diseases
Verified
Journal Article
Open access
PDF file
CPChan Kwon Park
Chan Kwon Park
SKSeung Joon Kim
Seung Joon Kim

1 May 2019 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
JLJeong Uk Lim
Jeong Uk Lim
CYChang Dong Yeo
Chang Dong Yeo
Chin Kook RheeChin Kook Rhee
Chin Kook Rhee
HKHye Seon Kang
Hye Seon Kang
CPChan Kwon Park
Chan Kwon Park
SLSang Haak Lee
Sang Haak Lee
Objectives: A significant proportion of non-small cell lung cancer (NSCLC) patients are never-smokers. However, the clinical impact of spirometrically diagnosed chronic obstructive pulmonary disease (COPD) on the prognosis of never-smoking NSCLC has not been evaluated in the context of treatment modalities and other cancer-related factors. In the present study, we evaluated the clinical impact of COPD in non-smoking NSCLC patients, and correlations between COPD and other previously unevaluated clinical variables. Materials and methods: Lung cancer patients (stages I to IV) diagnosed with NSCLC between January 2008 and December 2015 at six university hospitals were enrolled in the study cohort and retrospectively evaluated. Clinical parameters were compared between spirometrically diagnosed COPD and non-COPD groups. Correlations between COPD status and other variables were evaluated. In order to reduce the effect of potential confounders and selection bias, we performed adjustment for differences in baseline parameters by using propensity score matching (PSM). After PSM, clinical variables were evaluated for their effects on overall survival (OS). Results: Of the 345 patients enrolled in the study, 277 were categorized as non-COPD and 68 as COPD. Old age, male gender, and wild-type EGFR were significantly correlated with COPD. By univariate analysis of 218 patients in a propensity score matched cohort, not receiving active anticancer treatment, advanced stage, and COPD were significantly associated with shorter OS. Multivariate analysis showed that not receiving active anticancer treatment, advanced cancer stage, and COPD (P=0.044, HR: 1.526, 95% CI: 1.012–2.300) were significant predictors of shorter OS. Conclusion: In the present study, never-smoker NSCLC patients with COPD had shorter OS times, compared to non-COPD never-smoker NSCLC patients.

16 February 2016 in Experimental Hematology
Verified
Journal Article
Closed access
PDF file
SKSei Won Kim
Sei Won Kim
JLJi Young Lim
Ji Young Lim
Chin Kook RheeChin Kook Rhee
Chin Kook Rhee
JKJi Hye Kim
Ji Hye Kim
CPChan Kwon Park
Chan Kwon Park
HYHyoung Kyu Yoon
Hyoung Kyu Yoon

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
Byeong-Ho JeongByeong-Ho Jeong
Byeong-Ho Jeong
SLSang Haak Lee
Sang Haak Lee
HKHwan Hee Kim
Hwan Hee Kim
HYHo Il Yoon
Ho Il Yoon
JEJung Seop Eom
Jung Seop Eom
HKHojoong Kim
Hojoong Kim
Jeong BH, et al. J Korean Med Sci. 2022 Dec;38(3):e13. https://doi.org/10.3346/jkms.2023.38.e13

18 February 2022 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
CPChan Kwon Park
Chan Kwon Park
TATai Joon An
Tai Joon An
JKJi Hye Kim
Ji Hye Kim
Chin Kook RheeChin Kook Rhee
Chin Kook Rhee
HYHyoung Kyu Yoon
Hyoung Kyu Yoon